Adequan Dosing Chart For Dogs

At the approved dose 500 mg to achieve improvement shown in studies.

Adequan dosing chart for dogs.

Out of 123 dogs evaluated in clinical trials in canada and the united states only six dogs 5 experienced undesirable effects that might have been drug related. Medication should never be administered without first consulting your veterinarian. It has to be administered in a series of 8 injections. Use with caution in dogs with renal or hepatic impairment.

Veterinarians may repeat the 1 4 7 series as needed upon recurrence of the clinical signs of djd. Read on to learn about adequan for dogs the correct dosage safety precautions side effects and uses of the medicine. Do not exceed the recommended dose or therapeutic regimen. Dosing information of polysulfated glycosaminoglycan for dogs and cats.

At the recommended therapeutic dose and at double the recommended dose adequan canine has an excellent safety profile and injections are tolerated well. Dosage of adequan canine. Adverse reactions in clinical studies transient pain at injection site transient diarrhea and abnormal bleeding were mild and self limiting. The drug works by inhibiting one of the enzymes responsible for breaking down.

The recommended dose of adequan canine is 2 mg lb body weight 02 ml lb or 1 ml per 50 lb by intramuscular injection only twice weekly for up to 4 weeks maximum of 8 injections. Administer twice weekly for up to 4 weeks maximum of 8 injections at approved dosage of 2 mg lb body weight 0 02 ml lb or 1 ml 50 lb by intramuscular im injection only. It should be used with caution in dogs with renal or hepatic impairment. At early signs of degenerative joint disease veterinarians can administer adequan i m.

For dogs the dose is 1 mg to 2 5 mg per pound 2 to 5 mg kg in the muscle every 3 to 5 days for up to four weeks. Use adequan canine early at the first clinical signs of oa before it progresses and cartilage is irreversibly damaged. Possible adverse reactions were reported after 2 1 of the. Important safety information adequan canine should not be used in dogs who are hypersensitive to psgag or who have a known or suspected bleeding disorder.

Adequan canine is the only fda approved injectable disease modifying osteoarthritis drug dmoad for dogs. In the clinical efficacy trial 24 dogs were treated with adequan canine twice weekly for 4 weeks. It is a useful medication post surgery and is fast acting. Although improvement is generally observed after the second injection cartilage erosion ceases after the.

This dose of adequan canine should be injected intramuscularly twice a week for 4 weeks. It is recommended for the control of signs associated with non infectious degenerative and or traumatic arthritis of canine synovial joints. The recommended dosage is 2mg per pound of the dog s weight. The safe use of adequan canine used in breeding pregnant or lactating dogs has not been evaluated.